Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1956 2
1958 2
1959 1
1960 1
1961 1
1962 3
1977 1
1978 1
1980 2
1981 2
1982 1
1983 4
1984 8
1985 4
1986 4
1987 3
1988 2
1989 3
1990 4
1991 1
1992 4
1993 11
1994 6
1995 10
1996 9
1997 7
1998 9
1999 13
2000 13
2001 14
2002 3
2003 11
2004 12
2005 18
2006 8
2007 5
2008 7
2009 11
2010 10
2011 13
2012 11
2013 12
2014 13
2015 10
2016 16
2017 11
2018 11
2019 15
2020 12
2021 6
2022 7
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Results by year

Filters applied: . Clear all
Page 1
Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
Madsen AMR, Schaltz-Buchholzer F, Nielsen S, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, Dam C, Ditlev SB, Faizi G, Azizi M, Hameed ZN, Johansen IS, Kofoed PE, Krause TG, Kristensen GS, Loekkegaard ECL, Mogensen CB, Mohamed L, Oedegaard ES, Ostenfeld A, Soerensen MK, Wejse C, Netea MG, Aaby P, Benn CS. Madsen AMR, et al. Among authors: kristensen gs. J Infect Dis. 2024 Feb 14;229(2):384-393. doi: 10.1093/infdis/jiad422. J Infect Dis. 2024. PMID: 37774494 Clinical Trial.
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G, Clamp A, Farley J, Iyer G, Ray-Coquard I, Monk BJ. Grisham RN, et al. Among authors: kristensen g. Clin Cancer Res. 2023 Oct 13;29(20):4068-4075. doi: 10.1158/1078-0432.CCR-23-0621. Clin Cancer Res. 2023. PMID: 37581616 Free PMC article.
Recommendation for the design of stability studies on clinical specimens.
Gomez-Rioja R, Von Meyer A, Cornes M, Costelloe S, Vermeersch P, Simundic AM, Nybo M, Baird GS, Kristensen GBB, Cadamuro J; European Federation of Clinical Chemistry; Laboratory Medicine (EFLM) Working Group Preanalytical Phase (WG-PRE). Gomez-Rioja R, et al. Among authors: kristensen gbb. Clin Chem Lab Med. 2023 Apr 6;61(10):1708-1718. doi: 10.1515/cclm-2023-0221. Print 2023 Sep 26. Clin Chem Lab Med. 2023. PMID: 37021544 Free article.
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
Karamouza E, Glasspool RM, Kelly C, Lewsley LA, Carty K, Kristensen GB, Ethier JL, Kagimura T, Yanaihara N, Cecere SC, You B, Boere IA, Pujade-Lauraine E, Ray-Coquard I, Proust-Lima C, Paoletti X. Karamouza E, et al. Among authors: kristensen gb. Cancers (Basel). 2023 Mar 17;15(6):1823. doi: 10.3390/cancers15061823. Cancers (Basel). 2023. PMID: 36980708 Free PMC article.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer.
Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA. Guldvik IJ, et al. Among authors: kristensen g. Eur Urol Open Sci. 2022 Oct 4;45:68-75. doi: 10.1016/j.euros.2022.09.002. eCollection 2022 Nov. Eur Urol Open Sci. 2022. PMID: 36353660 Free PMC article.
364 results